Greenberg Traurig’s Evan Holden Speaks at National Academy of Sciences Roundtable on Biomedical Engineering Materials Applications

Share Article

Evan Holden, a shareholder in the Atlanta office of global law firm Greenberg Traurig, LLP, was a panelist at the National Academy of Sciences (NAS) Roundtable on Biomedical Engineering Materials Applications (BEMA) March 25 in Washington D.C. at NAS’ Keck Center.

Evan Holden, a shareholder in the Atlanta office of global law firm Greenberg Traurig, LLP, was a panelist at the National Academy of Sciences (NAS) Roundtable on Biomedical Engineering Materials Applications (BEMA), March 25 in Washington D.C. at NAS’ Keck Center. Holden, a member of the firm’s award-winning Pharmaceutical, Medical Device & Health Care Litigation Practice, addressed, “Medical Device Liability—How Do We Prevent Claims from the Get-Go?”

NAS is a private, nonprofit organization of the country’s leading researchers. The BEMA Roundtable brings together government officials, industry representatives, academics, and other leaders for discussions of issues related to research, development, applications, and regulation of biomedical materials and devices.  Holden’s panel discussed product liability law applicable to manufacturers of medical devices and strategies for companies to minimize risk and avoid litigation.

Holden represents life science companies, medical device manufacturers, global product manufacturers and Fortune 500 companies in the pharmaceutical and medical device industries. With over a decade of experience in products liability litigation, Holden is on the national counsel teams for some of the world’s largest medical device manufacturers and pharmaceutical companies. He also counsels clients on compliance matters, risk assessment, product recalls, and reporting activities governed by the Consumer Product Safety Commission, FDA, and other federal and state regulatory bodies. Holden is a core member of the team that was named American Lawyer’s 2018 “Product Liability Litigation Department of the Year” and 2018 “Georgia Regional Litigation Department of the Year.”

About Greenberg Traurig’s Pharmaceutical, Medical Device & Health Care Litigation Practice: The Pharmaceutical, Medical Device & Health Care Litigation Practice is an integral part of the firm’s 600-plus member national Litigation Practice. The team is nationally recognized for its dynamic courtroom presence, responsiveness to clients, and deep subject matter knowledge. Recent recognitions include national rankings for 2018 “Litigation Department of the Year” for Product Liability from The American Lawyer; 2017 “Products Liability & Mass Torts” from Chambers USA Guide; national rankings for 2017 “Practice Liability & Mass Torts Defense: Pharmaceuticals and Medical Devices” from The Legal 500 United States; and being named the Products Liability/Mass Torts Litigation Department of the Year by The Daily Report in 2013 and 2015 - 2017.  In addition, Greenberg Traurig is recognized as a “Product Liability Litigation Standout” in the BTI Litigation Outlook 2018 published by BTI Consulting Group.

About Greenberg Traurig, LLP: Greenberg Traurig, LLP (GT) has more than 2,000 attorneys in 39 offices in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lourdes Brezo-Martinez
@GT_Law
Follow >
Visit website